ROCHESTER, Minn. — Increasing access to high-quality health care and providing innovative, evidence-based care solutions to the communities it serves is a priority for Mayo Clinic Health System, even in the midst of an enduring global pandemic encompassing two years. One innovative therapeutic advancement used to prevent severe disease and death due to COVID-19 is called monoclonal antibody therapy. Mayo Clinic has one of the most robust monoclonal antibody programs in the country, and the…

from News from Mayo Clinic https://newsnetwork.mayoclinic.org/?p=327740